Cargando…
Deletion of Vascular Endothelial Growth Factor in myeloid cells accelerates tumorigenesis
Angiogenesis and the development of a vascular network is required for tumor progression, and involves release of angiogenic factors, including vascular endothelial growth factor (VEGF), from both malignant and stromal cell types(1). Infiltration by cells of the myeloid lineage is a hallmark of many...
Autores principales: | Stockmann, Christian, Doedens, Andrew, Weidemann, Alexander, Zhang, Na, Takeda, Norihiko, Greenberg, Joshua I., Cheresh, David A., Johnson, Randall S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103772/ https://www.ncbi.nlm.nih.gov/pubmed/18997773 http://dx.doi.org/10.1038/nature07445 |
Ejemplares similares
-
Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis
por: Ortiz, Berenice, et al.
Publicado: (2014) -
Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis
por: Astekar, Madhusudan, et al.
Publicado: (2012) -
A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation
por: Greenberg, Joshua I., et al.
Publicado: (2008) -
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
por: Weidemann, Anja K, et al.
Publicado: (2013) -
Vascular growth responses to chronic arterial occlusion are unaffected by myeloid specific focal adhesion kinase (FAK) deletion
por: Heuslein, Joshua L., et al.
Publicado: (2016)